- Home
- ONMD vs CRIS Comparison
ONMD vs CRIS Comparison
Compare ONMD & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONMD
- CRIS
- Stock Information
- Founded
- ONMD 2006
- CRIS 2000
- Country
- ONMD United States
- CRIS United States
- Employees
- ONMD N/A
- CRIS N/A
- Industry
- ONMD
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ONMD
- CRIS Health Care
- Exchange
- ONMD Nasdaq
- CRIS Nasdaq
- Market Cap
- ONMD 12.8M
- CRIS 21.3M
- IPO Year
- ONMD N/A
- CRIS 2000
- Fundamental
- Price
- ONMD $0.60
- CRIS $1.81
- Analyst Decision
- ONMD
- CRIS Strong Buy
- Analyst Count
- ONMD 0
- CRIS 2
- Target Price
- ONMD N/A
- CRIS $16.50
- AVG Volume (30 Days)
- ONMD 25.4M
- CRIS 163.8K
- Earning Date
- ONMD 05-14-2025
- CRIS 07-31-2025
- Dividend Yield
- ONMD N/A
- CRIS N/A
- EPS Growth
- ONMD N/A
- CRIS N/A
- EPS
- ONMD N/A
- CRIS N/A
- Revenue
- ONMD $532,000.00
- CRIS $11,202,000.00
- Revenue This Year
- ONMD N/A
- CRIS N/A
- Revenue Next Year
- ONMD N/A
- CRIS $10.67
- P/E Ratio
- ONMD N/A
- CRIS N/A
- Revenue Growth
- ONMD N/A
- CRIS 14.17
- 52 Week Low
- ONMD $0.30
- CRIS $1.02
- 52 Week High
- ONMD $1.60
- CRIS $8.29
- Technical
- Relative Strength Index (RSI)
- ONMD 60.28
- CRIS 43.58
- Support Level
- ONMD $0.53
- CRIS $1.50
- Resistance Level
- ONMD $0.66
- CRIS $1.98
- Average True Range (ATR)
- ONMD 0.09
- CRIS 0.19
- MACD
- ONMD 0.01
- CRIS -0.05
- Stochastic Oscillator
- ONMD 46.84
- CRIS 43.88
About ONMD OneMedNet Corp
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its innovative solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. OneMedNet's innovative technology proved the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade image-centric iRWDTM that exactly matches OneMedNet's life science partners' case selection protocols and paves the way for Real World Evidence.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.